Abstract. Different studies have revealed that the Ca 2+ -dependent serine/threonine phosphatase calcineurin is involved in the regulation of adipocyte differentiation. Calcineurin acts as a Ca 2+ -dependent molecular switch that negatively regulates the ability of 3T3-L1 cells to undergo adipocyte differentiation by preventing the expression of critical proadipogenic transcription factors. In this study we investigated the role of interleukin-15 (IL-15), a cytokine previously known to be involved in the control of fat accretion by adipose cells, in the differentiation of the 3T3-L1 preadipose cell line. We found that IL-15 is able to increase ·-calcineurin mRNA content in white adipose tissue of rats chronically treated with the cytokine and also in the 3T3-L1 preadipose cell line. Moreover, IL-15 promoted a decrease in both leptin mRNA expression and lipid accumulation, as estimated by Red Oil O staining. Cotreatment with IL-15 and FK506 (a calcineurin inhibitor) resulted in no changes in lipid content compared with the non-treated group. These data suggest that IL-15 directly inhibits adipogenesis, possibly by upregulating ·-calcineurin and preventing the induction of adipocyte differentiation.
Introduction
Adipocytes are highly specialized cells that play an important role in the regulation of energy homeostasis, insulin sensitivity, immunologic response and cardiovascular diseases (1, 2) . Adipose tissue development involves both cellular hypertrophy (increase in cell size as a result of excess triacylglycerol accumulation) and hyperplasia (increase in cell number as a result of increased de novo adipocyte differentiation) (3) . An excessive increase in the adipocyte hyperplasia and/or hypertrophy can lead to an accumulation of adipose tissue and consequently, obesity. Obesity is a multifactorial disorder that is a risk factor for other diseases including insulin resistance, type-2-diabetes and cancer (4) . For this reason, understanding the mechanisms that govern the regulation of differentiation and proliferation of adipose cells is of special interest because of the increasing incidence of obesity in developing countries (5) .
Different studies have demonstrated that increases in intracellular Ca 2+ concentration during the early phases of adipogenesis, both in human and 3T3-L1 adipocytes, causes a strong inhibition of the cellular differentiation process (6) . This effect seems to be regulated by calcineurin, a Ca 2+ -dependent serine/threonine phosphatase that is known to be a critical downstream effector of the Ca 2+ signal, and that mediates the Ca 2+ -dependent inhibition of adipocyte differentiation in 3T3-L1 cells (7) . It exists as a heterodimer formed by two subunits, calcineurin A, which has catalytic properties, and calcineurin B, with regulatory functions (8) . Following an increase in intracellular Ca 2+ concentrations, activated calcineurin binds and dephosphorylates the cytoplasm members of the nuclear factor of activated T cells (NFAT) family, unmasking two nuclear localization sequences and thus allowing their translocation to the nucleus, where they bind DNA and interact with other transcription factors such as AP-1 (9) .
It was demonstrated that specific calcineurin inhibitors (like cyclosporin A and FK506) overcame the anti-adipogenic effect of Ca 2+ ionophore on the differentiation of 3T3-L1 preadipocytes, and that the expression of a constitutive active calcineurin mutant inhibits adipocyte differentiation by preventing the expression of key transcription factors of adipocyte differentiation, peroxisome proliferation-activated receptor Á (PPARÁ) and CCAAT/ enhancer-binding protein · (C/EBP·) (7). In fact, previous studies suggest that NFAT proteins present in 3T3-L1 preadipocytes are implicated in the regulation of adipocyte differentiation and function (10) . Expression of an active NFAT mutant that constitutively localizes to the nucleus inhibits the capacity of 3T3-L1 cells to undergo adipocyte differentiation by inducing a state of cellular transformation (11 Of particular interest to the current study is the implication of interleukin-15 (IL-15) in the regulation of adipocyte differentiation and proliferation. IL-15 is a multifunctional cytokine firstly identified in the supernatant of the monkey epithelial cell line CV-1/EBNA which induces a broad range of effects inside the immune system (12, 13) . IL-15 mediates its functions through the ß and Á chains of the IL-2 receptor (14) , and the expression of its gene has been detected in the placenta, skeletal muscle, kidney, lung and heart (12) . We previously demonstrated that this cytokine can act as an autocrine anabolic factor for skeletal muscle (15) . In the course of in vivo studies regarding the effects of IL-15 on skeletal muscle, a 33% decrease in white adipose tissue (WAT) mass was observed in rats, with no changes in food intake (15, 16) . In another study using obese rodent models, a correlation was found between the sensitivity to the fat-inhibiting effects of IL-15 and the mRNA expression of key signalling subunits of the IL-15 receptor in WAT (17) , suggesting that IL-15 has a direct effect on this tissue. Additionally, Quinn et al (18) reported a direct inhibition of adipogenesis in 3T3-L1 cells, which is linked to a decrease in PPARÁ2, confirming the direct action of the cytokine on WAT. Bearing all this in mind, the aim of the present study was to analyze the effects of IL-15 on adipocyte differentiation and proliferation, relating to calcineurin mRNA expression under IL-15 treatment.
Materials and methods

Animals and treatments.
Male Wistar rats (Interfauna, Barcelona, Spain), weighing ~120-140 g, were used. The animals were maintained at 22±2˚C with a regular light-dark cycle (light on from 08:00 a.m. to 08:00 p.m.) and had free access to food and water. The diet (B.K. Universal G.J./S.L., Sant Vicenç del Horts, Barcelona, Spain) consisted of 45.5-48.5% carbohydrate (3.5% absorbable glucose, 42-45% starch), 18.5% protein and 3.1% fat (the residue was non digestible material). IL-15 was obtained from Immunex (Seattle, WA, USA). It was dissolved in sterile physiological saline and administered daily s.c. (100 μg/kg bw). Control animals received the same volume of vehicle. The animals were sacrificed after 7 days of cytokine administration. Food and water intake and body weight were measured daily. After 7 days of IL-15 treatment, animals were weighed and anaesthetized with an i.p. injection of ketamine/xylazine mixture (3:1) (Imalgene ® and Rompun ® respectively). Blood was collected from the abdominal aorta into heparinized tubes and centrifuged (3,500 x g, 10 min, 4˚C) to obtain plasma. Dorsal WAT was rapidly excised, weighed, and frozen in liquid nitrogen. All animal manipulations were made in accordance with the European Community guidelines for the use of laboratory animals.
Cell culture and adipocyte differentiation. 3T3-L1 preadipocytes (ATCC) were cultured in a growth medium of Dulbecco's modified Eagle's medium (DMEM) with high glucose (Invitrogen) supplemented with 10% (v/v) fetal calf serum, 25 mM HEPES pH 7.0, 1,000 units/ml penicillin and streptomycin each and 25 μg/ml fungizone (BioWhittaker). To induce adipocyte differentiation, cells were grown until 2 days postconfluence and then treated for 2 days with differentiation medium of DMEM with high glucose supplemented with 10% (v/v) fetal bovine serum (Invitrogen), 25 mM HEPES pH 7.0, 1000 units/ml penicillin and streptomycin each and 25 μg/ml fungizone, plus MDI (0.5 mM isobutylmethylxanthine, 0.25 μM dexamethasone and 5 μg/ml insulin, Sigma). At day 2 cells were re-fed with differentiation medium that only contained 5 μg/ml insulin instead of MDI, and every 2 days thereafter with differentiation medium alone. For the short-term study of the effects of the cytokine on adipogenesis, undifferentiated 3T3-L1 fibroblast cells were treated with 10 ng/ml IL-15 in sterile PBS (Promega) during 48 h after (referred herafter preadipocytes in short-term study) and before inducing differentiation (referred hereafter as differentiating adipocytes), or with vehicle solution. For the long-term study, 3T3-L1 cells were treated with either 10 ng/ml IL-15 (Peprotech) or PBS for 7 days before inducing differentiation (referred hereafter as pre-adipocytes in long-term study) and for 7 days after inducing differentiation (referred hereafter as 7d-adipocytes). All experimental groups were analyzed at the end of the treatment.
The calcineurin inhibition studies were carried out with 7d-adipocytes which were divided into four groups. Two groups received either 10 ng/ml IL-15 or PBS for 7 days. The third group received the calcineurin inhibitor FK506 (Sigma) at 5 ng/ml for the first 4 days after inducing differentiation, and the fourth group received 10 ng/ml IL-15 for 7 days and also 5 ng/ml FK506 for the 4 days indicated. All experimental groups were analyzed at the end of the treatment. After the different treatments, cells were fixed with paraformaldehyde 3% and stained with the lipophylic dye Oil Red O (Sigma) dissolved in isopropanol, as previously described (18) . Stained cells were visualized by bright field microscopy, measures of lipid content diameters were taken and then cells were photographed.
Reverse transcription-polymerase chain reaction. Total RNA was extracted from WAT or for different cultured cells with the TriPure reagent (Roche), and quantified spectrophotometrically. RNA integrity was checked by electrophoresis on 1.2% agarose gel, containing 10% 0.2 M MOPS and 18% formaldehyde.
·-calcineurin and leptin mRNA levels were analyzed by semiquantitative reverse-transcription polymerase chain reaction (RT-PCR) using the Kit Ready-to-Go RT-PCR Beads (Amersham). Aliquots of total RNA (0.5 μg for calcineurin and 0.2 μg for leptin) were added to an RT-PCR reaction mixture containing PCR buffer (10 mM Tris-HCl pH 9.0, 60 mM KCl, 1.5 mM MgCl 2 ), 2.0 units Taq DNApolymerase, 10 μM of each primer, and 200 μM dNTP. Oligonucleotide sequences were 5'ACT GGC ATG CTC CCC AGC GGA 3' and 3'GTG CCG TTA GTC TCT GAG GCG 5' primers for ·-calcineurin (resulting in a 214-pb product); 5'TTC ACA CAC GCA GTC GGT AT 3' and 3'CAT TCA GGG CTA AGG TCC AA 5' primers for leptin (resulting in a 366-pb product), accordingly to published sequences. Amplification conditions consisted of 1 min denaturation at 94˚C, 1 min annealing at 60˚C, and 2 min polymerization at 72˚C for each step for 27 cycles for calcineurin and 35 cycles for leptin, and extension at 72˚C for 7 min. PCR products were electrophoresed on 2% agarose gels and visualized with ethidium bromide. A standard DNA ladder was used to estimate the length of each PCR product. Quantification was performed by densitometric analysis. Individual product bands and representative background were excised from each gel lane and analyzed by means of specific software (Phoretix). The results were normalized for the level of 18S ribosomal subunit (5'CGC AGA ATT CCC ACT CCC GAC CC 3' and 3' CCC AAG CTC CAA CTA CGA GC 5' primers (resulting in a 256-pb product); denaturation (95˚C) 30 sec, annealing (55˚C) 1 min, polymerization (72˚C) 2 min, for 10 cycles, then extension (72˚C, 7 min).
Protein extraction and Western blotting. For protein extraction the cells were scraped in an ice cold buffer of 10 mM Tris pH 7.5, 10 mM EDTA, 400 mM NaCl, 10% glycerol, 0.5% Nonidet P-40, 5 mM NaF, and 0.01 mM sodium orthovanadate, in the presence of protease inhibitors and then sonicated for 10 sec. After that, the samples were centrifugated at 13,000 rpm for 10 min and the supernatants were collected and protein concentrations were determined according to the method of BCA (Pierce, USA). Equal amounts of protein (50 μg) were heat-denatured in sample-loading buffer (50 mM Tris-HCl pH 6.8, 100 mM DTT, 2% SDS, 0.1% bromophenol blue, 10% glycerol), resolved by SDS-polyacrylamide gel electrophoresis (8% polyacrylamide, 0.1% SDS) and transferred to Immobilon membranes (Immobilon PVDF, Millipore). The filters were blocked with PBS containing 5% of BSA and incubated with polyclonal antibodies, anti-·-calcineurin (Sigma) and antitubulin (Santa Cruz Biotechnology), which was used as an invariant control for the different studies. Donkey anti-mouse peroxidase-conjugated IgG (Jackson ImmunoResearch, Laboratories Inc., West Grove, USA) was used as secondary antibody. The membrane-bound immune complexes were detected by an enhanced chemiluminescence system (EZ-ECL, Biological Industries, Israel).
Statistical analysis. Statistical analysis of the data was performed by means of the Student's t test or oneway ANOVA.
Results
The results presented in Fig. 1 clearly show that treatment of animals with IL-15 for 7 days resulted in a significant increase (43%) in calcineurin mRNA expression in WAT. Interestingly, it has to be remarked that only one band (corresponding to 214 bp) was present in adipose tissue, in contrast with what was found in skeletal muscle, where two bands corresponding to the different mRNA isoforms of the · subunit of calcineurin were detected (Fig. 1) . Then we decided to analyze the modulation of ·-calcineurin mRNA expression during adipogenesis in the 3T3-L1 preadipose cell line. The results presented in Fig. 2 clearly show that, following induction of differentiation of preadipocytes to differentiated adipocytes, there was a significant decrease in ·-calcineurin mRNA levels ( Fig. 2A) . In addition, at day 7 of differentiation the ·-calcineurin protein content is also decreased (Fig. 2B) . 
A B
In order to analyze the effects of IL-15 on ·-calcineurin levels, we performed both short-and long-term studies (see Materials and methods). In the short-term study, IL-15 induced a significant upregulation of ·-calcineurin mRNA expression in both preadipocytes and differentiating adipocytes (Fig. 3A) . On the other hand, in the long-term study, only an increase in ·-calcineurin mRNA expression and protein content in 7d-adipocytes was observed ( Fig. 3B and C) .
It is accepted that the major part of expression changes needed to complete adipogenesis take place during the 48 h after the induction of differentiation (2) . With the aim of confirming the effects of IL-15 on adipocyte differentiation, we examined leptin mRNA content in both 7d-adipocytes with 7-day treatment with IL-15 during the pre-differentiation period and also in 7d-adipocytes with 7-day treatment with IL-15 during post-differentiation period. Interestingly, the results presented in Fig. 4 show that the treatment with the cytokine decreased the leptin mRNA expression levels in both types of cells (26% for preadipocytes and 22% for 7d-adipocytes.
Finally, we decided to analyze the implication of calcineurin in the effects of IL-15 on adipogenesis. For this reason we treated cells with IL-15, FK506 (inhibitor of calcineurin activity) or both. As seen in Fig. 5 , treatment with IL-15 for 7 days provoked a reduction of lipid content in 3T3-L1 cells which were differentiating (7d-adipocytes) as estimated by Red Oil O staining (Fig. 5A) and measured as diameter of lipid content of cells (Fig. 5B) .
Moreover, the treatment with FK506 blocked the effects of IL-15 on lipid accumulation in the 3T3-L1cells.
Discussion
Intracellular Ca
2+ seems to play a very important role in adipocyte differentiation as suggested by several studies (6, 7) . In fact, an increase in Ca 2+ concentrations during the earlier stages of adipogenesis both in human and 3T3-L1 adipocytes blocks the differentiating cellular process. Calcineurin, a Ca 2+ -dependent serine/threonine phosphatase, seems to be a key molecule in the regulation of the Ca 2+ effects on adipocyte differentiation. Indeed, following an increase in intracellular Ca 2+ there is an activation of calcineurin and a subsequent cascade of intracellular events that lead to a blockade of the differentiation process.
Bearing all this in mind, we decided to investigate the levels of ·-calcineurin in 3T3-L1 cells and their alterations during the A B C adipose differentiation process. For this reason, we analyzed both the mRNA and protein content at day 0 (preadipocytes) and following the induction of differentiation. There was a decrease (21%) in ·-calcineurin mRNA levels during the differentiation process. This effect was also observed in the protein level in 7d-adipocytes, suggesting that the changes in ·-calcineurin mRNA and protein are associated with the differentiation process. These results agree with the proposed role of calcineurin as an inhibitor of adipocyte differentiation (7, 11) . Therefore, a downregulation of calcineurin mRNA expression is necessary for a correct differentiation process. However, a persistent decreased level of calcineurin in 3T3-L1 may hamper the viability of differentiated cells since Ca 2+ is essential for them. Indeed, intracellular Ca 2+ has been described as necessary for lipogenesis in mature adipocytes (19) .
IL-15 is a cytokine related to the maintenance and activation of different immune system cells (12, 13) but also with multiple functions outside it. Several studies have related this cytokine with protein metabolism both in vitro (20) and in vivo (15) , demonstrating the anabolic effects of IL-15 on muscle tissue and cells. Interestingly, in the course of in vivo studies, it was observed that IL-15 treatment causes an important reduction in WAT mass, parallel to the effects on protein metabolism (16) . These effects seem to be direct in adipose tissue (17) , and are partially mediated by a lower uptake of triacylglycerols (16) and a reduction of lipogenesis (21) . Additionally, it was mentioned that indirect mechanisms by which lipid deposition in WAT could be affected, like a decrease on intestinal lipid absorption (22) and changes in liver lipogenic rate, leading to lipoproteins with a lower content in triacylglycerols. Moreover, a direct effect of IL-15 on culture cells, where this cytokine causes an inhibition of lipid accumulation in the preadipose cell line 3T3-L1 has been described (18) .
Taking into account the effects of IL-15 on lipid metabolism, we decided to analyze if the treatment with IL-15 causes any effect on calcineurin levels in adipose tissue, thus affecting the mechanism of adipose differentiation. Using the same experimental procedure previously described (15, 16) , the treated animals presented an increased calcineurin mRNA expression in adipose tissue, suggesting that some of the effects of IL-15 on WAT were calcineurin mediated. In order to test this possibility, we decided to investigate the effects of IL-15 on both undifferentiated and adipocyte cells. The results obtained clearly indicate that the cytokine increases the expression of mRNA of calcineurin, suggesting that this protein mediates the effects of IL-15. In addition, we investigated the leptin mRNA content following the addition of the cytokine to 3T3-L1 cells, which decrease in both preadipocytes and 7d-adipocytes, supporting the role of IL-15 in the inhibition of adipogenesis. To confirm the hypothesis suggesting that IL-15 affects differentiation via calcineurin, we inhibit calcineurin activity during adipocyte diffentiation by using FK506 as previously decribed (7) . The inhibition of calcineurin activity during adipogenesis did not affect lipid content in 7d-adipocytes; however, FK506 (a calcineurin inhibitor) abolished the inhibitory effect of IL-15 on lipid deposition in 3T3-L1 cultures.
Although further studies are necessary to confirm the calcineurin role in adipocyte differentiation, all these results allow us to suggest that the effects of IL-15 on adipocyte differentiation are partly mediated by calcineurin activity. 
